Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo.
about
Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysisQT interval prolongation after sertraline overdose: a case report.Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential AnalysisOmega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trialDDI-CPI, a server that predicts drug-drug interactions through implementing the chemical-protein interactome.SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment.Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic reviewSelective serotonin reuptake inhibitor efficacy in severe and melancholic depression.Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder.Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression.Dosing of Selective Serotonin Reuptake InhibitorsDr. Marken Replies.Preventive treatment of migraine: effect on weight.Nighttime heart rate predicts response to depression treatment in patients with coronary heart diseaseDose-response relationship of recent antidepressants in the short-term treatment of depression.Obstructive sleep apnea/hypopnea syndrome and poor response to sertraline in patients with coronary heart diseaseCardiac Risk Markers and Response to Depression Treatment in Patients With Coronary Heart Disease.The combination of triiodothyronine (T3) and sertraline is not superior to sertraline monotherapy in the treatment of major depressive disorder.Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder.Implementation of CYP2D6 genotyping in psychiatry.Improving adherence in mood disorders: the struggle against relapse, recurrence and suicide risk.Meta-analysis: A brief introduction.A Systematic Review of the Clinimetric Properties of the 6-Item Version of the Hamilton Depression Rating Scale (HAM-D6).A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors.Seeing double: sertraline and diplopia: a case report.The responsiveness of the different versions of the Hamilton Depression ScaleA critical review of selective serotonin reuptake inhibitor-related sexual dysfunction; incidence, possible aetiology and implications for management.A case of Ventricular Tachycardia and Cardiac Arrest Associated with Sertraline and Mirtazapine Combination.Adjunctive bright light in non-seasonal major depression.Trends in the use of selective serotonin reuptake inhibitors in nine Department of Veterans Affairs outpatient facilities.Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants.Adjunctive bright light in non-seasonal major depression: results from patient-reported symptom and well-being scales.Adjunctive bright light in non-seasonal major depression: results from clinician-rated depression scales.Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients.A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression.The generalizability of antidepressant efficacy trials to routine psychiatric out-patient practice.Sequential improvement of anxiety, depression and anhedonia with sertraline treatment in patients with major depression.Meta-analysis of placebo rates in major depressive disorder trials.
P2860
Q24647799-1DA714C8-68F9-402F-B44C-AE1FCA1A3031Q24812667-5764739E-2CDA-4F20-8BB9-13440837D3FBQ28736049-DDEC2904-E0E6-49FC-94C7-D6A4E94C85A8Q30876278-BAD1272E-5853-4C77-B2B3-65486091EB8FQ33860716-3FD28CA5-9A64-4D92-BAB3-98BACA3EC6ABQ34067137-83D66093-A624-4404-8BDA-6DC30FACB1ABQ34240696-B15A1D36-6A7D-4CE0-B8A6-484934D2F6ACQ34479180-E97B4395-B040-4F25-AFB1-F46C4362134DQ34617592-35BBAB17-1640-44BA-8C62-659DF5994985Q35046651-D6159345-E7F8-460D-8AE4-CB63DCDB02B5Q35666956-E099BFA0-744A-4DB2-B2BE-F1E07725D2E0Q35666973-83532227-3311-42D9-96D1-9DEBD6BC1FF1Q35987931-38CEEAA4-9932-4249-B376-7E484FD06609Q36005301-B9411FE5-1E04-45EA-91DF-0C8239B5C0BCQ36255130-FC2610A5-888D-43A4-B04D-13331659ED13Q36294918-0A588642-2000-4701-BB98-70550BCED3A5Q36418491-1519567B-9A13-4A04-A623-44AFEAA9DF01Q37141494-51074244-011A-47E8-8474-4B08E6F23467Q37156421-4C9AF308-0D2F-41DB-8D2C-D5CB478F0750Q37538787-B4B56C94-022A-4893-82EF-A74227F486F9Q37546078-D79D8EA7-7080-4BF0-82FF-37B35F98E3EBQ37700454-C35E3D4D-388F-430B-BE5A-590216E7754BQ38794012-809610F5-8253-476E-8008-A7F19000F746Q39703632-3065007E-C28D-492C-B0B2-C5662D2D8F44Q41119636-C91E27F3-A4FC-4C80-B1B2-0CCC8DBE8657Q41411632-368E5344-B28A-45DF-B373-F9F35D6E548AQ41428575-012D1A9E-AC42-4C0F-AD1D-1A92E5C8A859Q42171592-BA0AB7F7-AC0E-4C8D-AB9B-DE1C6A9B91ADQ45139944-4595D177-DB5D-49C4-8B49-CC1ACEA101FCQ45334852-EA42C4BA-2AFC-4CB5-A947-0EE5801534D4Q46182025-5178158D-E1CC-4E27-9FED-F8727357B063Q46475733-71E3F9E4-03DC-40BD-B4E3-ED545F501B9DQ46578584-1269E57D-F379-44B0-A433-790362F1BA90Q47899552-1077C2FD-CDEB-47F1-94D6-60B464E6D9BDQ48732179-EB74CDE1-6DE7-47E3-BF4A-1EC641A04F92Q48961678-5ADCF736-0A0D-4615-AE35-1B2A42501219Q51072003-6DF3989A-B424-43D8-8D45-BE279305C0BDQ51945431-B0DADA15-C007-42EC-B0E8-849D7FFB5043
P2860
Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Sertraline safety and efficacy ...... -dose comparison with placebo.
@en
Sertraline safety and efficacy ...... -dose comparison with placebo.
@nl
type
label
Sertraline safety and efficacy ...... -dose comparison with placebo.
@en
Sertraline safety and efficacy ...... -dose comparison with placebo.
@nl
prefLabel
Sertraline safety and efficacy ...... -dose comparison with placebo.
@en
Sertraline safety and efficacy ...... -dose comparison with placebo.
@nl
P2093
P1476
Sertraline safety and efficacy ...... -dose comparison with placebo.
@en
P2093
Abuzzahab FS
Claghorn JL
P304
P356
10.1016/0006-3223(95)00178-8
P407
P577
1995-11-01T00:00:00Z